Is this your product?Claim this existing listing to manage official product information after ownership approval.
Claim this tool
Healthcare Enterprise Only

Anumana

FDA-cleared ECG AI for earlier cardiovascular risk detection

Visit official website
PricingEnterprise Only
Starting priceContact sales
Free planUnknown
Free trialYes
APIUnknown
Open sourceNo
DeploymentClinical Workflow
Last verifiedAugust 2, 2026
Overview

Tool overview

Anumana is listed under Healthcare AI tools.

Summary

What is Anumana?

Anumana develops clinically validated ECG-AI algorithms that analyze standard 12-lead electrocardiograms to support earlier cardiovascular detection. Its commercially available ECG-AI LEF software aids clinicians in identifying low left ventricular ejection fraction and integrates into approved healthcare workflows.

Best fit

Best for

Healthcare providers adding regulated ECG AI to cardiac workflows

Audience

Who is it for?

CardiologistsPrimary-care cliniciansHospital leadersClinical technology teams
Recommendation

Decision note

Accepted for Preview after independent V411 official-source research. Apply only after failures = 0, warnings = 0, unmapped = 0, and review of controlled fields, Arabic v2 parity, outreach, affiliate status, logo QA, rebrand handling, and explicit clears.

Capabilities

Key features

AI analysis of standard 12-lead ECGs

FDA-cleared ECG-AI LEF algorithm

Clinical workflow and ECG-system integration

Evidence library and regulated instructions

Workflows

Use cases

Screening for low ejection fraction

Supporting earlier heart-failure evaluation

Adding AI insights to routine ECGs

Integrating cardiovascular AI in clinics

Strengths

Pros

  • Focused clinically validated use case
  • FDA-cleared commercial algorithm
  • Designed for existing ECG workflows
Considerations

Limitations

ECG-AI LEF is not a stand-alone diagnostic or monitoring device and should be used jointly with clinician judgment. Positive and negative results require interpretation within the patient context, indications for use, regulatory status, and appropriate follow-up evaluation.

Cost

Pricing details

Pricing modelEnterprise Only
Starting priceContact sales
Free planUnknown
Free trialYes
Pricing context

Billing options

Custom healthcare contract

Pricing context

Pricing note

Anumana directs healthcare organizations to contact the company for implementation and demonstrations. Public self-service pricing, an ongoing free plan, and a generally available free trial were not confirmed for the regulated clinical product.

View official pricing
Compatibility

Supported languages

  • English
Connectivity

Integrations

Philips ECG-AI Marketplace

Specs

Technical details

PlatformsWeb
Multilingual supportUnknown
Login requiredUnknown
Open sourceNo
DeploymentClinical Workflow
CompanyAnumana, Inc.
Launch year2021
Models / versionsECG-AI LEF 12-Lead Algorithm
Editions / plansECG-AI LEF
Data confidenceHigh
Last verifiedAugust 2, 2026
Decision hub

Finish your evaluation of Anumana

Move between similar tools, comparison cards, quick answers, user reviews, and open discussion without leaving the page.

Tools, comparisons & answers

Explore the best next step before choosing Anumana

Browse similar tools, open focused comparison cards, and answer the most common buying questions.

Answers

Frequently asked questions

Anumana develops clinically validated ECG-AI algorithms that analyze standard 12-lead electrocardiograms to support earlier cardiovascular detection. Its commercially available ECG-AI LEF software aids clinicians in identifying low left ventricular ejection fraction and integrates into approved healthcare workflows.
Healthcare providers adding regulated ECG AI to cardiac workflows
The listed pricing model for Anumana is Enterprise only. Pricing can change, so users should verify the latest plan details on the official website.
Yes. The current profile indicates that a free trial is available.
Community proof

User reviews

Real user feedback helps others understand strengths, limitations, and the best-fit workflows before choosing this tool.

No reviews Average rating
0 Total reviews
No reviews yet

Be the first to review Anumana

Share what worked, what did not, who this AI tool is best for, and what buyers should verify before choosing it.

Ask in discussion
Tool discussion

Ask or discuss this tool

Ask questions, share workflows, or discuss your experience with this AI tool.

ReplyContinue threads
EditUpdate your posts
ReportKeep it useful
0Total messages
0Threads
0Replies
Start a useful threadAsk, compare workflows, or reply to reviews

Keep it specific and helpful. You can edit or delete your own messages after posting.

Please log in to join the discussion.

Live discussion

Community messages

Reply to messages and keep the discussion useful. Use Report for abuse or spam. Your own posts can be edited or deleted.

No discussion yetBe the first to ask a question or share a useful workflow.